Skip to content

Clinical trials

Phase 1 Purpura, Thrombocytopenic, Idiopathic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Phase 1 Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20073
20101
20112
20121
20131
20142
20172
20182
20191
20201
20212
20221
20233
20248
20258
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting13
Unknown status6
Not yet recruiting6
Terminated5
Withdrawn1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Inc.4
Chongqing Peg-Bio Biopharm Co., Ltd.2
Chugai Pharmaceutical2
GlaxoSmithKline2
Jiangsu HengRui Medicine Co., Ltd.2
Peking University People's Hospital2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2
Baylor College of Medicine1
Bioverativ, a Sanofi company1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic47
Autoimmune Diseases4
Lupus Erythematosus, Systemic4
Anemia, Hemolytic, Autoimmune3
Arthritis, Rheumatoid3
Hematologic Diseases3
Myositis3
Antiphospholipid Syndrome2
Behcet Syndrome2
Blood Platelet Disorders2

Trials

Showing 51 to 47 of 47. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.